(A) Footpad swelling (compared to the uninfected contralateral footpad) (mm) of infected LTβR−/−, LTβ−/−, wt C57BL/6 (C57 +/+), and BALB/c mice (mean ± SE; n = 9 for C57BL/6 wt and LTβ−/− mice; n = 8 for LTβR−/− and BALB/c mice). 1, P < 0.05; 2, P < 0.01 (for differences between LTβR−/− and LTβ−/− mice). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (compared to results for wt C57BL/6 mice). (B to D) LDA of footpads (B), liver (C), or bone marrow (D) of LTβR−/−, LTβ−/−, wt C57BL/6 (C57+/+), or BALB/c mice 10 weeks after infection. The number of living parasites for single mice (diamonds) and the means for LTβR−/−, LTβ−/−, wt C57BL/6, and BALB/c mice (horizontal bars) are indicated. (E and F) Cytokine secretion of CD4+ cells isolated from spleens of LTβR−/−, LTβ−/−, wt C57BL/6 (C57+/+), or BALB/c mice 10 weeks after infection. Cells were incubated for 48 h with syngeneic DC stimulated for 48 h with soluble Leishmania antigen (sLmAg) (filled bars) or with unstimulated syngeneic DC (open bars). IFN-γ (E) or IL-4 (F) secretion was measured by ELISA (mean ± SE; n = 5). For panels B to F: *, P < 0.05; **, P < 0.01; ***, P < 0.001 (for differences between indicated mice).